Brazil's Enila in the dock as fatal practices confirmed
This article was originally published in Clinica
Executive Summary
Enila, the Brazilian manufacturer of the contrast agent Celobar, has had its trading licence withdrawn and a total of 72 products banned, at the end of an investigation into the cause of the death of 22 patients following radiological tests.